Bambusa Therapeutics Presented Positive Results from the Phase 1 Multiple Ascending Dose Trial of BBT001 at the 2026 American Academy of Dermatology (AAD) Annual Meeting Written by PR Newswire Enable JavaScript and cookies to continueRead more http://www.prnasia.com/story/archive/4924563_CN24563_0